Search

Your search keyword '"Califf, R.M."' showing total 268 results

Search Constraints

Start Over You searched for: Author "Califf, R.M." Remove constraint Author: "Califf, R.M."
268 results on '"Califf, R.M."'

Search Results

1. Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve

3. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. (Cardiovascular Medicine)

4. Lack of progress in cardiogenic shock: lessons from the GUSTO trials

5. P3622Timing of trial stoppage for non-inferiority trials and interpretation: lessons from ROCKET AF

6. Single bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 randomised trial

7. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

8. Selection of patients of reperfusion therapy for individual patients with evolving myocardial infarction

9. Role of diuretics, blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

12. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

15. Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

16. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

17. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

19. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomized trial

20. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010

21. Impediments to clinical research in the United States

22. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

23. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

24. Effect of valsartan on the incidence of diabetes and cardiovascular events

25. Effect of nateglinide on the incidence of diabetes and cardiovascular events

26. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

27. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction

28. Selection of reperfusion therapy for individual patients with evolving myocardial infarction

29. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.

30. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

31. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).

32. Early statin initiation and outcomes in patients with acute coronary syndromes.

33. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in unstable angina: receptor suppression using integreling therapy)

34. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

35. Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.

36. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

37. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction end- points in an international clinical trial: Review of the PURSUIT study

38. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention

39. Systematic adjudication of myocardial infarction end-points in an international clinical trial.

40. Lack of progress in cardiogenic shock: Lessons from the GUSTO trials

41. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation.

42. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators

43. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators

44. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

45. Stroke in Patients With Acute Coronary Syndromes: Incidence and Outcomes in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial

46. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study

47. Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes

49. Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis: Results from GUSTO-I

50. Selection of thrombolytic therapy for individual patients: development of a clinical model

Catalog

Books, media, physical & digital resources